Jeremy Sugarman

Dados Biográficos

ID3927965
NOMEJeremy Sugarman
PRENOMESJeremy
SOBRENOMESugarman
ASSINATURASUGARMAN J
AFILIAÇÕESJohns Hopkins University
VERIFICADONão
TOTAL DE OBRAS37
TOTAL DE CITAÇÕES30
TOTAL COMO AUTOR37
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO1994
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H3

  • Impact of Legal Perceptions and Disclosure on Willingness to Undergo HIV Antiretroviral Resistance Testing Among Men Who Have Sex with Men

    Open AccessCoralei E Neighbors, Thomas Sanchez et al.ARTICLEAIDS and Behavior2026

  • Prioritization of ethical concerns regarding HIV molecular epidemiology by public health practitioners and researchers

    Open AccessAnne Schuster, Anne L R Schuster et al.ARTICLEBMC Public Health2024

    The ethical issues of HIV ME vary in importance among stakeholders, reflecting different perspectives on the potential impact and usefulness of the data. Knowing these differences exist can directly inform the focus of future deliberations about the policies and practices of HIV ME in the United States

  • Developing a competency framework for health research ethics education and training

    Sean Tackett, Jane Sugarman et al.ARTICLEJournal of Medical Ethics2022

    Health research ethics (HRE) training programmes are being developed and implemented globally, often with a goal of increasing local capacity to assure ethical conduct in health-related research. Yet what it means for there to be sufficient HRE capacity is not well-defined, and there is currently no consensus on outcomes that HRE training programmes should collectively intend to achieve. Without defining the expected outcomes, meaningful evaluati…

  • Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials

    Open AccessStephanie R Morain, Stephanie A Kraft et al.ARTICLEThe Hastings Center Report2022

    Research ethics oversight systems have traditionally emphasized the informed consent process as the primary means by which to demonstrate respect for prospective subjects. Yet how researchers can best fulfill the ethical obligations of respect for persons in pragmatic clinical trials (PCTs)—particularly those that may alter or waive informed consent—remains unknown. We propose eight dimensions of demonstrating respect in PCTs: (1) engaging patien…

  • Allocation of Opportunities to Participate in Clinical Trials during the Covid‐19 Pandemic and Other Public Health Emergencies

    Open AccessKayte Spector‐Bagdady, Holly Fernandez Lynch et al.ARTICLEThe Hastings Center Report2022

    Covid‐19 raised many novel ethical issues including regarding the allocation of opportunities to participate in clinical trials during a public health emergency. In this article, we explore how hospitals that have a scarcity of trial opportunities, either overall or in a specific trial, can equitably allocate those opportunities in the context of an urgent medical need with limited therapeutic interventions. We assess the three main approaches to…

  • Barriers experienced by organ procurement organizations in implementing the Hope act and HIV-positive organ donation

    Zachary Predmore, Brianna Doby et al.ARTICLEAIDS Care2022

    In the seven years since the HIV Organ Policy Equity (HOPE) Act made HIV-positive organ donation to HIV-positive recipients legally permissible in the United States, there have been fewer HIV-positive organ donations than expected. Organ procurement organizations (OPOs) play a key role in the transplant system and barriers at OPOs may be partly responsible for the relatively low number of HIV-positive donors. To understand potential OPO barriers,…

  • Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    Open AccessRaphael J Landovitz, Deborah Donnell et al.ARTICLENew England Journal of Medicine2021

    BACKGROUND: Safe and effective long-acting injectable agents for preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection are needed to increase the options for preventing HIV infection. METHODS: We conducted a randomized, double-blind, double-dummy, noninferiority trial to compare long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) at a dose of 600 mg, given intramuscularly every 8 …

  • Rethinking Human Embryo Research Policies

    Open AccessKirstin R W Matthews, Ana S Iltis et al.ARTICLEThe Hastings Center Report2021

    It now seems technically feasible to culture human embryos beyond the “fourteen‐day limit,” which has the potential to increase scientific understanding of human development and perhaps improve infertility treatments. The fourteen‐day limit was adopted as a compromise but subsequently has been considered an ethical line. Does it remain relevant in light of technological advances permitting embryo maturation beyond it? Should it be changed and, if…

  • Perceptions, motivations, and concerns about living organ donation among people living with HIV

    Sarah E Van Pilsum Rasmussen, Macey L Henderson et al.ARTICLEAIDS Care2018

    Recent changes to United States law now permit people living with HIV (PLWH) to donate organs to HIV-infected (HIV+) recipients under research protocols. PLWH may have unique motivations for and concerns about living donation and understanding them is critical to ensuring the integrity of this novel approach to organ transplantation. We conducted in-depth interviews with PLWH from an urban HIV clinic who had previously indicated their willingness…

  • Comparison of Approaches for Notification and Authorization in Pragmatic Clinical Research Evaluating Commonly Used Medical Practices

    Kevin P Weinfurt, Juli M Bollinger et al.ARTICLEMedical Care2017Referências: 9

    BACKGROUND: For pragmatic clinical research comparing commonly used treatments, questions exist about if and how to notify participants about it and secure their authorization for participation. OBJECTIVE: To determine how patients react when they seek clinical care and encounter one of several different pragmatic clinical research studies. RESEARCH DESIGN: In an online survey using a between-subjects experimental design, respondents read and res…

  • Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials

    Open AccessBridget Haire, Morenike O Folayan et al.ARTICLEDeveloping World Bioethics2013

    The successful demonstration that antiretroviral ( ARV ) drugs can be used in diverse ways to reduce HIV acquisition or transmission risks – either taken as pre‐exposure prophylaxis ( PrEP ) by those who are uninfected or as early treatment for prevention ( T4P ) by those living with HIV – expands the armamentarium of existing HIV prevention tools. These findings have implications for the design of future HIV prevention research trials. With the …

  • Guidelines for International Service Learning Programs

    Open AccessJohn A Crump, Jane Sugarman et al.ARTICLEDeveloping World Bioethics2011

  • Goals of Medicine in the Course of History and Today

    Jane Sugarman, Jeremy SugarmanARTICLEBulletin of the history of medicine2007

    Reviewed by: Goals of Medicine in the Course of History and Today: A Study in the History and Philosophy of Medicine Jeremy Sugarman Kurt Fleischhauer and Göran Hermerén . Goals of Medicine in the Course of History and Today: A Study in the History and Philosophy of Medicine. Stockholm: Kungl. Vitterhets Historie och Antikvitets Akademien, 2006. 480 pp. SEK 366.00 (91-7402-353-5). This volume is the product of collaboration between a physician (K…

  • Bioethics Consultation in the Private Sector

    Baruch A Brody, Baruch Brody et al.ARTICLEGekauftes Gewissen?2007Citada por: 3

    Bioethics consultation is flourishing in the private sector. The corporate clients are aware that their work raises substantive ethical issues, and often they are concerned about how their response to these issues may affect their public image and their financial standing. Many are prepared to compensate ethics consultants at substantial rates. This is a new phenomenon for the field of bioethics. Traditionally, most requests for comment and analy…

  • Measuring Trust in Medical Researchers

    Mark A Hall, Fabian Camacho et al.ARTICLEMedical Care2006Referências: 21

    BACKGROUND: Concern is widespread that the public's and participants' trust in medical research is threatened, but few empirical measures of research trust exist. This project aims to enable more rigorous study of researcher trust by developing and testing appropriate survey measures. METHODS: Survey items were developed based on a conceptual model of the primary domains of researcher trust (safety, fidelity, honesty, global trust). Pilot testing…

  • Policy & Politics

    Jane Sugarman, Jeremy SugarmanARTICLEThe Hastings Center Report2005

    Jeremy Sugarman, Policy & Politics: Should the Gold Rule? Assessing "Equivalent Protections" for Research Participants across International Borders, The Hastings Center Report, Vol. 35, No. 5 (Sep. - Oct., 2005), pp. 12-13

  • Ethical Goals of Community Consultation in Research

    Neal W Dickert, Neal Dickert et al.ARTICLEAmerican Journal of Public Health2005Citada por: 17Referências: 31

    In response to the traditional emphasis on the rights, interests, and well-being of individual research subjects, there has been growing attention focused on the importance of involving communities in research development and approval. Community consultation is a particularly common method of involving communities. However, the fundamental ethical goals of community consultation have not been delineated, which makes it difficult for investigators…

  • The Limitations of “Vulnerability” as a Protection for Human Research Participants

    Carol Levine, Ruth Faden et al.ARTICLEThe American Journal of Bioethics2004

    Vulnerability is one of the least examined concepts in research ethics. Vulnerability was linked in the Belmont Report to questions of justice in the selection of subjects. Regulations and policy documents regarding the ethical conduct of research have focused on vulnerability in terms of limitations of the capacity to provide informed consent. Other interpretations of vulnerability have emphasized unequal power relationships between politically …

  • Moral Standards for Research in Developing Countries from "Reasonable Availability" to "Fair Benefits"

    Maged El Setouhy, Tsiri Agbenyega et al.ARTICLEThe Hastings Center Report2004

    Maged El Setouhy, Tsiri Agbenyega, Francis Anto, Christine Alexandra Clerk, Kwadwo A. Koram, Michael English, Rashid Juma, Catherine Molyneux, Norbert Peshu, Newton Kumwenda, Joseph Mfutso-Bengu, Malcolm Molyneux, Terrie Taylor, Doumbia Aissata Diarra, , Mamadou Sylla, Dione Youssouf, Catherine Olufunke Falade, Segun Gbadegesin, Reidar Lie, Ferdinand Mugusi, David Ngassapa, Julius Ecuru, Ambrose Talisuna, Ezekiel Emanuel, Christine Grady, Elizabe…

  • A Reference in Research Ethics

    Jane Sugarman, Jeremy Sugarman et al.ARTICLEIRB Ethics and Human Research2004

    Education in the ethics of research with human participants has now moved well beyond secluded seminars in graduate schools. For example, the National Institutes of Health now requires research ethics education for principal investigators and key personnel who receive extramural funding. Similarly, recipients of federal training grants in science must provide education in the responsible conduct of research for their trainees. Academic medical ce…

  • Improving Informed Consent

    Patricia Agre, Frances A Campbell et al.ARTICLEIRB Ethics and Human Research2003

    Patricia Agre, Frances A. Campbell, Barbara D. Goldman, Maria L. Boccia, Nancy Kass, Laurence B. McCullough, Jon F. Merz, Suzanne M. Miller, Jim Mintz, Bruce Rapkin, Jeremy Sugarman, James Sorenson, Donna Wirshing, Improving Informed Consent: The Medium Is Not the Message, IRB: Ethics & Human Research, Vol. 25, No. 5, Supplement (Sep. - Oct., 2003), pp. S11-S19

  • Conducting Empirical Research on Informed Consent

    Greg A Sachs, Gavin W Hougham et al.ARTICLEIRB Ethics and Human Research2003

    Greg A. Sachs, Gavin W. Hougham, Jeremy Sugarman, Patricia Agre, Marion E. Broome, Gail Geller, Nancy Kass, Eric Kodish, Jim Mintz, Laura W. Roberts, Pamela Sankar, Laura A. Siminoff, James Sorenson, Anita Weiss, Conducting Empirical Research on Informed Consent: Challenges and Questions, IRB: Ethics & Human Research, Vol. 25, No. 5, Supplement (Sep. - Oct., 2003), pp. S4-S10

  • Research Oversight through New Lenses

    Jane Sugarman, Jeremy Sugarman et al.ARTICLEIRB Ethics and Human Research2003

    Jeremy Sugarman, Lisa A. Eckenwiler, Ezekiel J. Emanuel, Research Oversight through New Lenses: The Consortium to Examine Clinical Research Ethics, IRB: Ethics & Human Research, Vol. 25, No. 1 (Jan. - Feb., 2003), pp. 9-10

  • Empirical Research on Informed Consent with the Cognitively Impaired

    Gavin W Hougham, Greg A Sachs et al.ARTICLEIRB Ethics and Human Research2003

    Gavin W. Hougham, Greg A. Sachs, Deborah Danner, Jim Mintz, Marian Patterson, Laura W. Roberts, Laura A. Siminoff, Jeremy Sugarman, Peter J. Whitehouse, Donna Wirshing, Empirical Research on Informed Consent with the Cognitively Impaired, IRB: Ethics & Human Research, Vol. 25, No. 5, Supplement (Sep. - Oct., 2003), pp. S26-S32

  • Back to the Rough Ground

    Kathleen M Macqueen, Jane Sugarman et al.ARTICLEIRB Ethics and Human Research2003

    Kathleen M. MacQueen, Jeremy Sugarman, Back to the Rough Ground: Working in International HIV Prevention as Ethical Debates Continue, IRB: Ethics & Human Research, Vol. 25, No. 2 (Mar. - Apr., 2003), pp. 11-13